93 7351 93 7351 (Lansoprazole delayed release 30 mg)

Pill imprint 93 7351 93 7351 has been identified as Lansoprazole delayed release 30 mg.

Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; aspiration pneumonia (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 7351 93 7351

Lansoprazole delayed release 30 mg 93 7351 93 7351
Lansoprazole delayed release 30 mg 93 7351 93 7351
Lansoprazole delayed release
Imprint:
93 7351
93 7351
Strength:
30 mg
Color:
Gray & Pink
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7351
Inactive Ingredients:
ferrosoferric oxide
gelatin
hypromellose 2910 (6 mPa.s)
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
propylene glycol
ferric oxide red
shellac
sucrose
corn starch
magnesium silicate
titanium dioxide
triethyl citrate
potassium hydroxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-6086 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)